➡ Upstream Target
alzheimer
Identification:MR+RCT+CRISPRi
✗ KILL CRITERIA
- TREM2 deficiency does not affect amyloid plaque burden in models
- Microglial TREM2 activation has no effect on tau pathology
- TREM2 variants are not associated with AD risk in large GWAS